eriodictyol has been researched along with resveratrol in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
Bicknell, KA; Farrimond, JA; Putnam, SE; Swioklo, S; Watson, KA; Williamson, EM | 1 |
Gawas, UB; Majik, MS; Mandrekar, VK | 1 |
Aziz, A; Boitel-Conti, M; Borie, N; Clément, C; Courot, E; Hubert, J; Jeandet, P; Lequart, M; Maurin, N; Nuzillard, JM; Pilard, S; Renault, JH; Tisserant, LP | 1 |
1 review(s) available for eriodictyol and resveratrol
Article | Year |
---|---|
Next generation quorum sensing inhibitors: Accounts on structure activity relationship studies and biological activities.
Topics: 4-Butyrolactone; Anti-Bacterial Agents; Biofilms; Cobalt; Coordination Complexes; Drug Design; Furans; Quorum Sensing; Staphylococcus aureus; Structure-Activity Relationship | 2020 |
3 other study(ies) available for eriodictyol and resveratrol
Article | Year |
---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
Topics: Cell Differentiation; Flavonoids; Humans; Mesenchymal Stem Cells; Molecular Structure; Osteogenesis; Signal Transduction; Structure-Activity Relationship | 2015 |
Topics: Benzofurans; Chromatography, Liquid; Cyclopentanes; Flavanones; Flavonoids; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Oxylipins; Phenols; Plant Roots; Polycyclic Compounds; Resveratrol; Stilbenes; Vitis | 2016 |